Drugs / chlormadinone acetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT01608698 | Jun 2012 → Jan 2016 | — | Mahidol University | Unknown | Met primary |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT01123538 Comparator | Dec 2008 → Oct 2011 | — | University Hospital of North Norway | Unknown | No outcome recorded |
| — | NCT00842140 Background | Feb 2006 → Jan 2009 | polycystic ovary syndrome | University of Sao Paulo | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chlormadinone acetate | “oral contraceptive (0,03mg ethynylestradiol and 2mg chlormadinone acetate)once a day for 12 months” NCT00842140 ↗ |
| Known as | Chlormadinone | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Known as | Clormadinona | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Known as | Luteran | “5 mg/day oral chlormadinone acetate (e.g. Luteran® 5mg)+ 0.05 mg/day transdermal (i.e. plaster) 17β-estradiol (e.g. Estraderm® 50µg)” NCT01123538 ↗ |
| Known as | Lutoral | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Known as | Normenon | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Known as | NSC-92338 | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Known as | RS-1280 | ChEMBL registry synonym — accepted as the source's own label CHEMBL110691 ↗ |
| Modality | Small molecule | — CHEMBL110691 ↗ |
| Route | Oral | “oral contraceptive (0,03mg ethynylestradiol and 2mg chlormadinone acetate)once a day for 12 months” NCT00842140 ↗ |
| Target | PGR | “Progesterone receptor modulator” CHEMBL110691 ↗ |